Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Forma Therapeutics
Biotech
Novo Nordisk plows $1.1B for Forma Therapeutics with eye on SCD
Novo Nordisk is paying out $1.1 billion to acquire Forma Therapeutics, a biotech aiming to treat rare blood disorders like sickle cell disease (SCD).
Gabrielle Masson
Sep 1, 2022 11:30am
Rigel bets $230M on Forma's leukemia drug
Aug 2, 2022 4:01pm
FDA shores up executive team with 2 hires—Chutes & Ladders
Jul 1, 2022 9:30am
Forma builds case for FT-4202 in competitive sickle cell space
Mar 30, 2021 8:40am
Forma Therapeutics' IDH1 drug clears leukemia in 33% of patients
Oct 26, 2020 10:30am
Olema Oncology brings on AZ vet Bohen as CEO—Chutes & Ladders
Sep 18, 2020 9:30am
